Balaxi Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 10.18 | 10.00 | 10.00 | 10.00 | 3.04 |
| Share application money | 10.30 | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 71.63 | 47.91 | 33.25 | 18.11 | 0.48 |
| Loan funds | |||||
| Secured loans | 10.75 | - | - | - | - |
| Unsecured loans | - | 1.93 | 3.51 | - | - |
| Total | 102.86 | 59.84 | 46.75 | 28.11 | 3.52 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 8.41 | 2.45 | 0.78 | 0.19 | 0.01 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 0.52 | 0.25 | 0.09 | 0.01 | - |
| Net block | 7.89 | 2.20 | 0.69 | 0.19 | 0.01 |
| Capital work-in-progress | 2.83 | 0.57 | - | - | - |
| Investments | 19.54 | 19.61 | 19.54 | 0.10 | - |
| Net current assets | |||||
| Current assets, loans & advances | 99.46 | 59.53 | 48.69 | 37.62 | 6.10 |
| Less : current liabilities & provisions | 26.87 | 22.07 | 22.17 | 9.79 | 2.59 |
| Total net current assets | 72.60 | 37.46 | 26.52 | 27.83 | 3.51 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 102.86 | 59.84 | 46.75 | 28.11 | 3.52 |
| Notes: | |||||
| Book value of unquoted investments | - | 19.61 | 19.54 | 0.10 | - |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | - | - | - | - | - |
| Number of equity sharesoutstanding (Lacs) | 101.81 | 100.00 | 100.00 | 100.00 | 30.40 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis